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Figure 1 
 
 
 
Alternative pathways for conversion of 18:3n-3 to longer chain PUFA. ?Indicates reactions where 
the identity of the elongase is not known in PBMCs or Jurkat cells. 
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Figure 2 
 
 
 
Mass of [13C]-labelled fatty acids per µg cell protein in PBMCs and Jurkat cells incubated for 48 
hours with [13C]-18:3n-3.  Values are mean ± SEM.  (A) PBMCs from men and women (n = 34); 
(B) Individual n-3 PUFA as a proportion of total n-3 PUFA in commercially prepared PBMCs with 
or without SC26196 (n = 5 culture replicates per treatment). (C) [13C] Enrichment of n-3 PUFA in 
Jurkat cells (n = 9 culture replicates).  (D)  [13C]enrichment of n-3 PUFA in Jurkat cells with or 
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without SC26196 (n = 6 culture replicates per treatment).  Means that differed significantly by 
student’s t test are indicated by *P < 0.05, **P<0.001, ***P<0.0001.    
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Figure 3 
 
 
 
mRNA expression of (A) FADS2, (B) FADS1, (C) ELOVL4, (D) ELOVL5 and (E) ELOVL 2 in 
PBMCs either unstimulated or stimulated with Con. A from men plus women (n = 34), or Jurkat 
leukaemia cells (n = 13 culture replicates).  Statistical analysis was by 1-way ANOVA with 
Tukey’s post hoc test for multiple comparisons. 
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Figure 4 
 
 
 
The effect of SC26196 (200nM) on the proliferation of stimulated PBMCs after hours incubation 
(A-C) and on Jurkat cells (D).  (A) proliferation index; (B) division index and (C) proportion of 
cells that underwent cell division (n = 10 culture replicates).  (D) Jurkat cells were incubated with 
or without 200nm SC26196 for 144 hours.  Cell proliferation was measured by cell counting.  
Statistical analysis of PBMCs was by Student’s paired (A-C) or unpaired (D) t test.  
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Figure 5 
 
 
 
 
 
Digests of 5’ RACE PCR – pRACE clones with EcoR1 and HindIII.  –C, unstimulated PBMCs; 
+C, stimulated PBMCs; JK, Jurkat cells; +Ctrl, RACE positive control; ntc, no template control. 
Arrow indicates FADS2 transcript. 
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Figure 6.   
 
 
Methylation status of (A,B) individual CpG loci in the 5’-regulatory region of FADS2 and (C,D) an 
intergenic putative enhancer (1) in PBMCs.  Values are mean  SEM.  (n = 33 paired unstimulated 
and Con A stimulated PBMCs from men plus women).  Means which differed significantly between 
stimulated and unstimulated PBMCs by Students paired t test are indicated by *P < 0.05; **P < 
0.01; ***P<0.001.  (B) and (D) show the change (stimulated minus unstimulated) in % methylation.  
(A) Methylation status of individual CpG loci in unstimulated compared to stimulated  PBMCs 
cells (B) The change in % methylation of individual CPG loci in unstimulated compared to 
stimulated PBMCs.  (C) Methylation status of individual CpG loci in the 5’regulatory region of 
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FADS2 in unstimulated compared to stimulated PBMCs. (D) The change in % methylation between 
of individual CpG loci in the FADS2 putative enhancer region in unstimulated compared to 
stimulated PBMCs.   
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Figure 7. 
 
 
 
Methylation status of (A,B) individual CpG loci in the 5’-regulatory region of FADS2 and (C,D) an 
intergenic putative enhancer (1) in PBMCs compare to Jurkat cells.  Values are mean  SEM.  (n = 
33 unstimulated PBMCs from men plus women and n = 10 Jurkat cell culture replicates).  Means 
which differed significantly between stimulated and unstimulated PBMCs by Students paired t test 
are indicated by *P < 0.05; **P < 0.01; ***P<0.001.  (A) Methylation status of individual CpG loci 
in unstimulated PBMCs compared to Jurkat cells.  (B) The difference in % methylation between the 
mean level of methylation of individual CPG loci in PBMCs compared to Jurkat cells.  (C) 
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Methylation status of individual CpG loci in the 5’regulatory region of FADS2 in unstimulated 
PBMCs compared to Jurkat cells. (D) The difference in % methylation between the mean level of 
methylation of individual CpG loci in PBMCs compared to Jurkat cells. 
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  Figure 8. 
 
 
 
 
 
A model to explain the role of PUFA synthesis in immune cell activation.  Cell activation induces 
up-regulation of the mRNA expression and activity of the enzymes encoded by FADS2, FADS2, 
ELOVL5 and ELOVL4 leading to increased synthesis of PUFA up to 22:5n-3 via 8 desaturation.  
The lack of ELOVL2 mRNA expression and 22:6n-3 synthesis, accompanied by increased ELOVL 
4 expression suggests that instead of interconversion to 22:6n-3, newly synthesised n-3 PUFA could 
be used to synthesise VLCPUFA, which are known to be involved in the assembly of lipid rafts (2).  
This may facilitate the activation of signalling processes that are required for cell proliferation.  
Solid arrows represent known reactions, dotted arrows represent putative reactions in leukocytes.  X 
Indicates reactions that appear to not occur in leukocytes. 
